Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29326 - 29350 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Daunorubicin	Approved Investigational	BAX	581	upregulated	Daunorubicin results in increased expression of BAX mRNA	19q13.33	A21904
Daunorubicin	Approved Investigational	BCL2	596	downregulated	Daunorubicin results in decreased expression of BCL2 mRNA	18q21.33	A21906
Daunorubicin	Approved Investigational	CAB39	51719	downregulated	Daunorubicin results in decreased expression of CAB39 mRNA	2q37.1	A20666
Daunorubicin	Approved Investigational	CACNA1G	8913	downregulated	Daunorubicin results in decreased expression of CACNA1G mRNA	17q21.33	A21904
Daunorubicin	Approved Investigational	CACNA2D2	9254	downregulated	Daunorubicin results in decreased expression of CACNA2D2 mRNA	3p21.31	A21904
Daunorubicin	Approved Investigational	CCND3	896	upregulated	Daunorubicin results in increased expression of CCND3 mRNA	6p21.1	A21905
Daunorubicin	Approved Investigational	CCNG2	901	upregulated	Daunorubicin results in increased expression of CCNG2 mRNA	4q21.1	A21907
Daunorubicin	Approved Investigational	CDC25A	993	upregulated	Daunorubicin results in increased expression of CDC25A mRNA	3p21.31	A21905
Daunorubicin	Approved Investigational	CDKN1A	1026	upregulated	Daunorubicin results in increased expression of CDKN1A mRNA	6p21.2	A21905
Daunorubicin	Approved Investigational	CDKN2B	1030	upregulated	Daunorubicin results in increased expression of CDKN2B mRNA	9p21.3	A21905
Daunorubicin	Approved Investigational	CEACAM1	634	upregulated	Daunorubicin results in increased expression of CEACAM1 mRNA	19q13.2	A20666
Daunorubicin	Approved Investigational	CEBPZ	10153	downregulated	Daunorubicin results in decreased expression of CEBPZ mRNA	2p22.2	A20666
Daunorubicin	Approved Investigational	CKM	1158	downregulated	Daunorubicin results in decreased expression of CKM mRNA	19q13.32	A21904
Daunorubicin	Approved Investigational	CLK2	1196	upregulated	Daunorubicin results in increased expression of CLK2 mRNA	1q22	A21905
Daunorubicin	Approved Investigational	CORIN	10699	downregulated	Daunorubicin results in decreased expression of CORIN mRNA	4p12	A21904
Daunorubicin	Approved Investigational	DMD	1756	downregulated	Daunorubicin results in decreased expression of DMD mRNA	Xp21.2-p21.1	A21904
Daunorubicin	Approved Investigational	DUSP4	1846	upregulated	Daunorubicin results in increased expression of DUSP4 mRNA	8p12	A21904
Daunorubicin	Approved Investigational	E2F5	1875	upregulated	Daunorubicin results in increased expression of E2F5 mRNA	8q21.2	A21905
Daunorubicin	Approved Investigational	EI24	9538	upregulated	Daunorubicin results in increased expression of EI24 mRNA	11q24.2	A20666
Daunorubicin	Approved Investigational	EPM2AIP1	9852	upregulated	Daunorubicin results in increased expression of EPM2AIP1 mRNA	3p22.2	A20666
Daunorubicin	Approved Investigational	ERBB3	2065	downregulated	Daunorubicin results in decreased expression of ERBB3 mRNA	12q13.2	A21904
Daunorubicin	Approved Investigational	F3	2152	upregulated	Daunorubicin results in increased expression of F3 mRNA	1p21.3	A20814
Daunorubicin	Approved Investigational	FAS	355	upregulated	Daunorubicin results in increased expression of FAS mRNA	10q23.31	A21904
Daunorubicin	Approved Investigational	FDXR	2232	upregulated	Daunorubicin results in increased expression of FDXR mRNA	17q25.1	A20666
Daunorubicin	Approved Investigational	GDF15	9518	upregulated	Daunorubicin results in increased expression of GDF15 mRNA	19p13.11	A21904

Displaying entries 29326 - 29350 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability